Cancer Clinical Trials in Moscow

25 recruitingMoscow, Russia

Showing 1–20 of 25 trials

Recruiting

Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia

Breast Cancer
Novartis Pharmaceuticals2,766 enrolled34 locationsNCT06930859
Recruiting
Phase 1

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Metastatic Castration-resistant Prostate Cancer (mCRPC)Small Cell Lung Cancer ( SCLC )Follicular Lymphoma ( FL)
Pfizer453 enrolled82 locationsNCT03460977
Recruiting

Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers

Esophageal CancerGastric CancerBrain Metastases
Blokhin's Russian Cancer Research Center30 enrolled1 locationNCT07464470
Recruiting

Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esophagogastric Junction Cancer

Gastric Cancer (GC)Siewert Type III Adenocarcinoma of Esophagogastric JunctionSiewert Type II Adenocarcinoma of Esophagogastric Junction
P. Herzen Moscow Oncology Research Institute300 enrolled1 locationNCT07441785
Recruiting

TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation

Bladder Cancer
AstraZeneca600 enrolled19 locationsNCT07038928
Recruiting

Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration

Prostate Cancer
AstraZeneca400 enrolled18 locationsNCT07052578
Recruiting

An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

Endometrial Cancer
AstraZeneca500 enrolled21 locationsNCT07041606
Recruiting
Phase 2

Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)

Gastric Cancer
AstraZeneca450 enrolled100 locationsNCT04379596
Recruiting

Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world Practice

Breast Cancer
Novartis Pharmaceuticals240 enrolled5 locationsNCT06905301
Recruiting
Phase 2

A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors

Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal CancerPart 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
AstraZeneca468 enrolled123 locationsNCT04482309
Recruiting
Phase 1Phase 2

A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1

Breast Cancer MetastaticRenal Cell Carcinoma MetastaticProstate Cancer Metastatic+2 more
Kidney Cancer Research Bureau58 enrolled5 locationsNCT07292168
Recruiting

Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

Prostate Cancer
AstraZeneca400 enrolled17 locationsNCT07146113
Recruiting
Phase 2

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Prostate Cancer
Astellas Pharma Global Development, Inc.900 enrolled241 locationsNCT02960022
Recruiting
Not Applicable

A Study to Assess the Efficiency of Trastuzumab Deruxtecan in Russian Breast Cancer Patients

HER2-positive Breast CancerTrastuzumab Deruxtecan
Blokhin's Russian Cancer Research Center60 enrolled1 locationNCT07281001
Recruiting
Not Applicable

Feasibility Trial of Single-Dose Radiotherapy for Localized Low and Intermediate Risk Prostate Cancer

Prostate Cancer
Branch Office of "Hadassah Medical Ltd"30 enrolled1 locationNCT07112781
Recruiting
Phase 3

A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer
Mabscale, LLC620 enrolled28 locationsNCT05654454
Recruiting
Phase 3

Prophylactic Mesh Placement During Stoma Closure After Low Anterior Resection

SurgeryRectal CancerNeoplasms Malignant+1 more
Blokhin's Russian Cancer Research Center142 enrolled1 locationNCT05939687
Recruiting
Phase 2

Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer

Colorectal, Cancer
Blokhin's Russian Cancer Research Center30 enrolled1 locationNCT06428487
Recruiting
Not Applicable

D2 vs D3 Lymph Node Dissection for Left Colon Cancer

Colon Cancer
Russian Society of Colorectal Surgeons1,381 enrolled1 locationNCT04364373
Recruiting

Effects of Oncological Treatment During Pregnancy on Mother and Child

CancerPregnancy
University Hospital, Gasthuisberg5,000 enrolled33 locationsNCT00330447